| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|
| 1h-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- | [no description available] | medium | 2 | 0 | benzazepine | |
| spiperone | [no description available] | medium | 7 | 0 | aromatic ketone;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound | alpha-adrenergic antagonist;
antipsychotic agent;
dopaminergic antagonist;
psychotropic drug;
serotonergic antagonist |
| sk&f-38393 | [no description available] | medium | 1 | 0 | 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol | |
| pergolide | [no description available] | medium | 1 | 0 | diamine;
methyl sulfide;
organic heterotetracyclic compound | antiparkinson drug;
dopamine agonist |
| etisulergine | [no description available] | medium | 1 | 0 | | |
| 5-hydroxy-2-n,n-dipropylaminotetralin | [no description available] | medium | 3 | 0 | | |
| n 0437, (-)-isomer | [no description available] | medium | 3 | 0 | tetralins | |
| n 0734 | [no description available] | medium | 2 | 0 | | |
| 7-hydroxy-2-n,n-dipropylaminotetralin, (r)-isomer | [no description available] | medium | 1 | 0 | | |
| 5-hydroxy-2-n,n-dipropylaminotetralin, (s)-isomer | [no description available] | medium | 1 | 0 | | |
| haloperidol | [no description available] | medium | 1 | 0 | aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol | antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist |
| oseltamivir | [no description available] | medium | 1 | 0 | acetamides;
amino acid ester;
cyclohexenecarboxylate ester;
primary amino compound | antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
environmental contaminant;
prodrug;
xenobiotic |
| glycolipids | [no description available] | medium | 1 | 0 | | |
| sulpiride | [no description available] | medium | 4 | 0 | benzamides;
N-alkylpyrrolidine;
sulfonamide | antidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist |
| 8-hydroxy-2-(di-n-propylamino)tetralin | [no description available] | medium | 2 | 0 | phenols;
tertiary amino compound;
tetralins | serotonergic antagonist |
| pirimicarb | [no description available] | medium | 1 | 0 | aminopyrimidine;
carbamate ester;
tertiary amino compound | agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic |
| guanylyl imidodiphosphate | [no description available] | medium | 1 | 0 | nucleoside triphosphate analogue | |
| carbamates | [no description available] | medium | 1 | 0 | amino-acid anion | |
| apomorphine | [no description available] | medium | 1 | 0 | aporphine alkaloid | alpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug |
| prazosin | [no description available] | medium | 1 | 0 | aromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines | alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
| bromocriptine | [no description available] | medium | 2 | 0 | indole alkaloid | antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
hormone antagonist |
| clozapine | [no description available] | medium | 1 | 0 | benzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound | adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic |
| quinpirole | [no description available] | medium | 3 | 0 | pyrazoloquinoline | dopamine agonist |
| jl 18 | [no description available] | medium | 1 | 0 | | |
| sk&f-38393 | [no description available] | medium | 6 | 0 | benzazepine;
catechols;
secondary amino compound | |
| naxagolide | [no description available] | medium | 1 | 0 | organic heterotricyclic compound;
phenols;
tertiary amino compound | anticonvulsant;
antiparkinson drug;
dopamine agonist |
| cy 208-243 | [no description available] | medium | 1 | 0 | phenanthridines | |
| 7-hydroxy-2-n,n-dipropylaminotetralin | [no description available] | medium | 1 | 0 | tetralins | |
| choline | [no description available] | medium | 2 | 0 | cholines | allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite |
| 1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester | [no description available] | medium | 1 | 0 | | |
| bq 610 | [no description available] | medium | 1 | 0 | | |
| tetraethylammonium | [no description available] | medium | 1 | 0 | quaternary ammonium ion | |
| egtazic acid | [no description available] | medium | 1 | 0 | diether;
tertiary amino compound;
tetracarboxylic acid | chelator |
| iberiotoxin | [no description available] | medium | 1 | 0 | | |
| charybdotoxin | [no description available] | medium | 1 | 0 | | |
| hemicholinium 3 | [no description available] | medium | 1 | 0 | | |
| oxotremorine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine | |
| pentobarbital | [no description available] | medium | 1 | 0 | barbiturates | GABAA receptor agonist |
| physostigmine | [no description available] | medium | 1 | 0 | carbamate ester;
indole alkaloid | antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic |
| atropine | [no description available] | medium | 1 | 0 | | |
| pimozide | [no description available] | medium | 1 | 0 | benzimidazoles;
heteroarylpiperidine;
organofluorine compound | antidyskinesia agent;
dopaminergic antagonist;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist |
| piperidines | [no description available] | medium | 1 | 0 | | |
| eticlopride | [no description available] | medium | 3 | 0 | salicylamides | |
| u 101958 | [no description available] | medium | 1 | 0 | | |
| alpha-aminopyridine | [no description available] | medium | 1 | 0 | | |
| alpha,beta-methyleneadenosine 5'-triphosphate | [no description available] | medium | 1 | 0 | nucleoside triphosphate analogue | |
| estradiol 3-benzoate | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid;
benzoate ester | estrogen receptor agonist;
xenoestrogen |
| metergoline | [no description available] | medium | 1 | 0 | carbamate ester;
ergoline alkaloid | dopamine agonist;
geroprotector;
serotonergic antagonist |
| n-(4-aminophenethyl)spiroperidol | [no description available] | medium | 2 | 0 | aromatic ketone | |
| guanosine triphosphate | [no description available] | medium | 1 | 0 | guanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate | Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor |
| 2-aminotetralin | [no description available] | medium | 1 | 0 | tetralins | |
| thiophenes | [no description available] | medium | 2 | 0 | mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound | non-polar solvent |
| 4-butyrolactone | [no description available] | medium | 1 | 0 | butan-4-olide | metabolite;
neurotoxin |
| reserpine | [no description available] | medium | 1 | 0 | alkaloid ester;
methyl ester;
yohimban alkaloid | adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic |
| racemetirosine | [no description available] | medium | 1 | 0 | | |
| am 580 | [no description available] | low | 0 | 0 | amidobenzoic acid;
tetralins | antineoplastic agent;
retinoic acid receptor alpha/beta agonist |
| liranaftate | [no description available] | low | 0 | 0 | tetralins | |
| nadolol | [no description available] | low | 0 | 0 | tetralins | |
| tramazoline | [no description available] | low | 0 | 0 | tetralins | |
| tetralin | [no description available] | low | 0 | 0 | ortho-fused bicyclic hydrocarbon;
tetralins | |
| 6-Methoxy-1-tetralone | [no description available] | low | 0 | 0 | tetralins | |
| be 2254 | [no description available] | low | 0 | 0 | tetralins | |
| 5,6-dihydroxy-2-dimethylaminotetralin | [no description available] | low | 0 | 0 | tetralins | |
| mibefradil | [no description available] | low | 0 | 0 | tetralins | T-type calcium channel blocker |
| 5,6,7,8-tetrahydro-1-naphthol | [no description available] | low | 0 | 0 | tetralins | |
| sertraline | [no description available] | low | 0 | 0 | dichlorobenzene;
secondary amino compound;
tetralins | antidepressant;
serotonin uptake inhibitor |
| acetyl methyl tetramethyl tetralin | [no description available] | low | 0 | 0 | tetralins | |
| tamibarotene | [no description available] | low | 0 | 0 | dicarboxylic acid monoamide;
retinoid;
tetralins | antineoplastic agent;
retinoic acid receptor alpha/beta agonist |
| aj 76 | [no description available] | low | 0 | 0 | secondary amino compound;
tetralins | dopaminergic antagonist |
| oxoline | [no description available] | low | 0 | 0 | aromatic ketone;
tetralins | geroprotector |
| lasofoxifene | [no description available] | low | 0 | 0 | aromatic ether;
N-alkylpyrrolidine;
naphthols;
tetralins | antineoplastic agent;
bone density conservation agent;
cardioprotective agent;
estrogen receptor agonist;
estrogen receptor antagonist |
| isoshinanolone | [no description available] | low | 0 | 0 | tetralins | |
| 3-(4-chlorophenyl)-2-methyl-3,3a,4,5-tetrahydrobenzo[g]indazole | [no description available] | low | 0 | 0 | tetralins | |
| N1-(5-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide | [no description available] | low | 0 | 0 | tetralins | |
| eptazocine | [no description available] | low | 0 | 0 | tetralins | |
| 1-(1H-imidazol-5-ylsulfonyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | tetralins | |
| 4-oxo-4-[5-(1,2,3,4-tetrahydronaphthalen-1-ylsulfamoyl)-2,3-dihydroindol-1-yl]butanoic acid | [no description available] | low | 0 | 0 | tetralins | |
| 2-phenoxy-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]acetamide | [no description available] | low | 0 | 0 | tetralins | |
| 1-(phenylmethyl)-3-(1,2,3,4-tetrahydronaphthalen-1-yl)thiourea | [no description available] | low | 0 | 0 | tetralins | |
| 4-phenyl-2-propionamidotetraline | [no description available] | low | 0 | 0 | tetralins | |
| a 61603 | [no description available] | low | 0 | 0 | tetralins | |
| N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]cyclohexanecarboxamide | [no description available] | low | 0 | 0 | tetralins | |
| 2-chloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | tetralins | |
| 2-(4-chlorophenoxy)-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]acetamide | [no description available] | low | 0 | 0 | tetralins | |
| 2,6-difluoro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | tetralins | |
| 2,4-dichloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | tetralins | |
| 8-methoxy-2-propionamidotetralin | [no description available] | low | 0 | 0 | tetralins | |
| sr 59230a | [no description available] | low | 0 | 0 | tetralins | |
| 7-hydroxy-2-(n-n-propyl-n-(3-iodo-2'-propenyl)-amino)tetralin | [no description available] | low | 0 | 0 | organoiodine compound;
phenols;
tertiary amino compound;
tetralins | dopamine agonist |
| pseudopteroxazole | [no description available] | low | 0 | 0 | tetralins | metabolite |
| 8-hydroxy-2-(di-n-propylamino)tetralin, (r)-isomer | [no description available] | low | 0 | 0 | tetralins | |
| uh 232 | [no description available] | low | 0 | 0 | tetralins | |
| 4-[(2,1,3-benzothiadiazol-4-ylsulfonylamino)methyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-cyclohexanecarboxamide | [no description available] | low | 0 | 0 | tetralins | |
| nepicastat | [no description available] | low | 0 | 0 | 1,3-dihydroimidazole-2-thiones;
organofluorine compound;
primary amino compound;
tetralins | EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor |
| NNC 55-0396 (free base) | [no description available] | low | 0 | 0 | benzimidazoles;
cyclopropanecarboxylate ester;
organofluorine compound;
tertiary amino compound;
tetralins | angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
neuroprotective agent;
potassium channel blocker;
T-type calcium channel blocker |
| (S)-Isosclerone | [no description available] | low | 0 | 0 | tetralins | |
| PB28 | [no description available] | low | 0 | 0 | aromatic ether;
piperazines;
tetralins | anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
sigma-2 receptor agonist |
| (+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside | [no description available] | low | 0 | 0 | beta-D-glucoside;
dimethoxybenzene;
lignan;
monosaccharide derivative;
polyphenol;
primary alcohol;
tetralins | antibacterial agent;
antifungal agent;
metabolite |
| eptazocine hydrobromide | [no description available] | low | 0 | 0 | tetralins | |
| lyoniresinol | [no description available] | low | 0 | 0 | dimethoxybenzene;
lignan;
polyphenol;
primary alcohol;
tetralins | antineoplastic agent;
metabolite |
| N-[2-methyl-5-(2-thiazolo[5,4-b]pyridinyl)phenyl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide | [no description available] | low | 0 | 0 | tetralins | |
| N-methyl-N-(3-pyridinylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yloxymethyl)-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | tetralins | |